Jurg Schwitter
Overview
Explore the profile of Jurg Schwitter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gut P, Cochet H, Antiochos P, Caluori G, Durand B, Constantin M, et al.
Diagn Interv Imaging
. 2024 Dec;
PMID: 39667998
Purpose: The purpose of this study was to introduce and evaluate a novel two-dimensional wideband black-blood (BB) LGE sequence, incorporating wideband inversion recovery, wideband T2 preparation, and non-rigid motion correction...
2.
Gut P, Cochet H, Caluori G, El-Hamrani D, Constantin M, Vlachos K, et al.
Magn Reson Med
. 2024 Jun;
92(5):1851-1866.
PMID: 38852175
Purpose: Wideband phase-sensitive inversion recovery (PSIR) late gadolinium enhancement (LGE) enables myocardial scar imaging in implantable cardioverter defibrillators (ICD) patients, mitigating hyperintensity artifacts. To address subendocardial scar visibility challenges, a...
3.
Guglielmo M, Arangalage D, Bonino M, Angelini G, Bonanni M, Pontone G, et al.
J Cardiovasc Magn Reson
. 2023 Jun;
25(1):32.
PMID: 37316826
Objectives: The identification of patients with mitral valve prolapse (MVP) presenting high arrhythmic risk remains challenging. Cardiovascular Magnetic Resonance (CMR) feature tracking (FT) may improve risk stratification. We analyzed the...
4.
Pavon A, Rubimbura V, Nowacka A, Hocquelet A, Schwitter J, Rotzinger D
Front Cardiovasc Med
. 2023 Jun;
10:1100916.
PMID: 37273871
Hepatic microwave ablation (MWA) is a growing treatment modality in the field of primary and secondary liver cancer. One potential side effect is thermal damage to adjacent structures, including the...
5.
Antiochos P, Masi A, Maurizi N, Monney P, Schwitter J
Rev Med Suisse
. 2023 May;
19(828):1015-1022.
PMID: 37222641
Cardiovascular magnetic resonance (CMR) is an imaging modality with growing indications in cardiology. The purpose of this article is to illustrate the current clinical applications of CMR across the spectrum...
6.
Bamps L, Armenti J, Bojan M, Grandbastien B, von Garnier C, Du Pasquier R, et al.
J Clin Med
. 2023 Apr;
12(7).
PMID: 37048757
Long-lasting symptoms after SARS-CoV-2 infection have been described many times in the literature and are referred to as Long COVID. In this prospective, longitudinal, monocentric, observational study, we collected the...
7.
Skalidis I, Lu H, Antiochos P, Pitta Gros B, Auberson D, Domenichini G, et al.
Rev Med Suisse
. 2023 Jan;
19(N° 809-10):16-24.
PMID: 36660831
The year of 2022 was marked by many novelties in the fields of interventional cardiology, heart failure, electrophysiology, cardiac imaging, and congenital heart disease. These advances will certainly change our...
8.
AlAref S, Altibi A, Malkawi A, Mansour M, Baskaran L, Masri A, et al.
Eur Heart J Cardiovasc Imaging
. 2022 Jul;
24(4):472-482.
PMID: 35792682
Aims: Right ventricular systolic dysfunction (RVSD) is an important determinant of outcomes in heart failure (HF) cohorts. While the quantitative assessment of RV function is challenging using 2D-echocardiography, cardiac magnetic...
9.
Buso G, Darioli R, Calanca L, Depairon M, Schwitter J, Mazzolai L, et al.
Eur J Intern Med
. 2022 Feb;
99:63-69.
PMID: 35135705
Background: Lower limb peripheral arterial disease (PAD) is a leading atherosclerotic disease in the elderly. However, awareness of the disease is poor, particularly in women. Methods: In this retrospective, cross-sectional...
10.
Acute cardiac manifestations under immune checkpoint inhibitors-beware of the obvious: a case report
Arangalage D, Pavon A, Ozdemir B, Michielin O, Schwitter J, Monney P
Eur Heart J Case Rep
. 2021 Aug;
5(8):ytab262.
PMID: 34423240
Background: Immune checkpoint inhibitors (ICI) have revolutionized the management of many cancer types by drastically improving the median survival rate of patients. However, this efficiency comes at the cost of...